The company’s platform integrates protein science expertise with structural biology, machine learning algorithms designed to analyze many millions of known proteins and peptides, looking for statistical patterns linking amino-acid sequence, structure, and function, data science, and computational infrastructure, which is supplemented with Generate’s own proprietary experimental data. The platform can also generate antibodies designed to bind specific epitopes on desired targets, allowing in silico generation of potent antibodies on demand . . .

Get GEN Edge Today!

See More on the Edge

Continue reading this article and more
with a GEN Edge subscription

Start Your 30-Day Free Trial Now

Log In Join GEN Edge